OptiNose Raises $48.5 Million
OptiNose, a developer of nasal drug delivery technology, has secured a $48.5 million private equity commitment from Avista Capital Partners. The company also announced that it will move its headquarters from Norway to Yardley, Pennsylvania. Existing backer WFD Ventures will retain a "significant stake" in the company.
8 June 2010•4 mins read
